Back to search

Switzerland· 58543003

Salvacyl, poudre et solvant pour suspension injectable à libération prolongée

A triptorelin product containing triptorelinum, registered in Switzerland by Debiopharm Research & Manufacturing SA and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 11 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC L02AE04

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedSalvacyl, poudre et solvant pour susp…ATCL02AE04REGISTER NO.58543003PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Triptorelin is registered in 11 of 19 countries.

Countries holding a registration under ATC L02AE04 (triptorelin), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 7 of them publish a price we can compare per daily dose

Triptorelin · ATC L02AE04

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of triptorelin costs, country by country.

Normalised to the WHO defined daily dose (0.1 mg), so markets compare like for like.

  • Switzerland: $3.91 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Triptorelin · price per daily dose (0.1 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$3.91
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Swissmedic (Switzerland)
Active substance
triptorelinum
Manufacturer
Debiopharm Research & Manufacturing SA
Country
Switzerland (CH)
ATC code
L02AE04
ATC class
Triptorelin
Defined daily dose
0.1 mg, P
Swissmedic category
B
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680585430039
    Set 1 Stk
    CHF 334.05

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

321 interactions on record for triptorelin.

Graded by severity as the source publishes them — 69 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Triptorelin · interactions on record

321 records

  • 69 severe
  • 249 moderate
  • 3 minor

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • QuinidineC01BA01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Triptorelin in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All triptorelin products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Pamorelin La, Salvacyl
  • Belgium · Decapeptyl, Decapeptyl Sustained Release
  • Bulgaria · Диферелин, Диферелин S.R.
  • Cyprus · Arvekap
  • Czechia · Diphereline, Diphereline S.R.
  • Germany · Pamorelin La, Salvacyl
  • Denmark · Pamorelin
  • Estonia · Diphereline
  • Spain · Decapeptyl Diario, Decapeptyl Mensual
  • Finland · Pamorelin
  • France · Decapeptyl (S.C.), Decapeptyl L.P. (I.M.) Sur 28 Jours
  • United Kingdom (Northern Ireland) · Gonapeptyl Depot
  • Greece · Arvekap, Salvapar
  • Croatia · Decapeptyl Cr
  • Hungary · Diphereline, Diphereline Sr
  • Ireland · Decapeptyl 3-Month, Decapeptyl 6-Month
  • Italy · Decapeptyl, Gonapeptyl Depot
  • Lithuania · Diphereline
  • Luxembourg · Decapeptyl, Decapeptyl Sustained Release
  • Latvia · Diphereline
  • Netherlands · Decapeptyl-Cr, Pamorelin
  • Norway · Pamorelin
  • Poland · Diphereline, Diphereline Sr
  • Portugal · Decapeptyl, Decapeptyl Lp
  • Romania · Diphereline, Diphereline Pr
  • Sweden · Pamorelin
  • Slovenia · Diphereline, Pamorelin
  • Slovakia · Diphereline, Diphereline S.R.

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cc259ab7-3920-4eff-8df5-83894c2cc29a
GET /v1/drugs/cc259ab7-3920-4eff-8df5-83894c2cc29a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "triptorelinum 11.25 mg",
  "valid_from": "2019-02-01",
  "limitations": "[{\"description\":\"Verschreibung ausschliesslich durch einen Psychiater. Begleitend zur Pharmakotherapie muss eine patientengerechte und auf die Reduktion der paraphilen Symptomatik ausgerichtete Psychotherapie erfolgen.\",\"costApproval\":null,\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2019-02-01\"}]",
  "galenic_form": "Trockensub 11.25 mg c Solv (Adapter)",
  "therapeutic_area": null,
  "sl_inclusion_date": "2012-11-01",
  "self_retention_pct": 10
}

See everything about triptorelin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.